These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16310251)

  • 1. Episomal vectors to monitor and induce somatic hypermutation in human Burkitt-Lymphoma cell lines.
    Rückerl F; Busse B; Bachl J
    Mol Immunol; 2006 Apr; 43(10):1645-52. PubMed ID: 16310251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation-induced cytidine deaminase fails to induce a mutator phenotype in the human pre-B cell line Nalm-6.
    Rückerl F; Bachl J
    Eur J Immunol; 2005 Jan; 35(1):290-8. PubMed ID: 15593119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual reporter system to dissect cis- and trans-effects influencing the mutation rate in a hypermutating cell line.
    Ruckerl F; Mailhammer R; Bachl J
    Mol Immunol; 2004 Nov; 41(12):1135-43. PubMed ID: 15482849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AID mutates a non-immunoglobulin transgene independent of chromosomal position.
    Parsa JY; Basit W; Wang CL; Gommerman JL; Carlyle JR; Martin A
    Mol Immunol; 2007 Jan; 44(4):567-75. PubMed ID: 16542725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.
    Hackney JA; Misaghi S; Senger K; Garris C; Sun Y; Lorenzo MN; Zarrin AA
    Adv Immunol; 2009; 101():163-89. PubMed ID: 19231595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
    Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
    Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AID in tumorigenesis.
    Okazaki IM; Kotani A; Honjo T
    Adv Immunol; 2007; 94():245-73. PubMed ID: 17560277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation-induced deaminase: light and dark sides.
    de Yébenes VG; Ramiro AR
    Trends Mol Med; 2006 Sep; 12(9):432-9. PubMed ID: 16861038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of somatic hypermutation.
    Odegard VH; Schatz DG
    Nat Rev Immunol; 2006 Aug; 6(8):573-83. PubMed ID: 16868548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Target sequence accessibility limits activation-induced cytidine deaminase activity in primary mediastinal B-cell lymphoma.
    Popov SW; Moldenhauer G; Wotschke B; Brüderlein S; Barth TF; Dorsch K; Ritz O; Möller P; Leithäuser F
    Cancer Res; 2007 Jul; 67(14):6555-64. PubMed ID: 17638864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas.
    Martin A; Bardwell PD; Woo CJ; Fan M; Shulman MJ; Scharff MD
    Nature; 2002 Feb; 415(6873):802-6. PubMed ID: 11823785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of class switch recombination function in fish activation-induced cytidine deaminase, AID.
    Wakae K; Magor BG; Saunders H; Nagaoka H; Kawamura A; Kinoshita K; Honjo T; Muramatsu M
    Int Immunol; 2006 Jan; 18(1):41-7. PubMed ID: 16291656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts.
    Yoshikawa K; Okazaki IM; Eto T; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Science; 2002 Jun; 296(5575):2033-6. PubMed ID: 12065838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Directed molecular evolution by somatic hypermutation.
    Wang CL; Yang DC; Wabl M
    Protein Eng Des Sel; 2004 Sep; 17(9):659-64. PubMed ID: 15516361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of activation-induced cytidine deaminase in B cells.
    Muto T; Okazaki IM; Yamada S; Tanaka Y; Kinoshita K; Muramatsu M; Nagaoka H; Honjo T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2752-7. PubMed ID: 16477013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma.
    Greiner A; Tobollik S; Buettner M; Jungnickel B; Herrmann K; Kremmer E; Niedobitek G
    J Pathol; 2005 Apr; 205(5):541-7. PubMed ID: 15732141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
    Pérez-Durán P; de Yebenes VG; Ramiro AR
    Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral vectors to monitor somatic hypermutation.
    Klasen M; Spillmann FJ; Lorens JB; Wabl M
    J Immunol Methods; 2005 May; 300(1-2):47-62. PubMed ID: 15936027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of human AID in yeast induces mutations in context similar to the context of somatic hypermutation at G-C pairs in immunoglobulin genes.
    Mayorov VI; Rogozin IB; Adkison LR; Frahm C; Kunkel TA; Pavlov YI
    BMC Immunol; 2005 Jun; 6():10. PubMed ID: 15949042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation.
    Smit LA; van Maldegem F; Langerak AW; van der Schoot CE; de Wit MJ; Bea S; Campo E; Bende RJ; van Noesel CJ
    Haematologica; 2006 Jul; 91(7):903-11. PubMed ID: 16818277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.